Altimmune, Inc.
USD3.08
+0.14 (+4.59%)
CEO
Jerome Benedict Durso
IPO Date
2017-05-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.95
Prev. Close
$2.94
Day Low
$2.91
Day High
$3.14
52W Low
$2.56
52W High
$6.44
Market Cap
$0.27B
Volume
3.10M
| -5.4 |
| 31 Dec 2023 | FY | 100.0% | -20762.2% | -45.6% | -42.0% | 0.00 | 17.26 | -6.8 |
| 31 Dec 2022 | FY | 100.0% | 124577.9% | -45.7% | -40.9% | 0.01 | 11.31 | -9.1 |
| 31 Dec 2021 | FY | 100.0% | -2201.6% | -48.8% | -44.4% | 0.01 | 11.17 | -3.9 |
| 31 Dec 2020 | FY | -309.4% | -599.2% | -21.7% | -20.0% | 0.01 | 19.16 | -5.9 |
| 31 Dec 2019 | FY | 100.0% | -353.7% | -45.1% | -38.0% | 0.04 | 10.04 | -1.2 |
| 31 Dec 2018 | FY | -78.7% | -379.2% | -81.1% | -71.5% | 0.01 | 8.70 | -0.1 |
| 31 Dec 2017 | FY | -44249.4% | -111860.3% | -95.4% | -73.7% | 0.00 | 6.11 | -0.5 |
| 31 Dec 2016 | FY | -38.1% | 3706.4% | 996.2% | 86.3% | 0.05 | 1.09 | 0.2 |
| -3.3 |
| 30 Sept 2025 | Q3 | -299100.0% | -380280.0% | -10.2% | -8.7% | 0.09 | 17.18 | -4.4 |
| 30 Jun 2025 | Q2 | 100.0% | -442920.0% | -13.7% | -11.6% | 0.10 | 20.44 | -3.6 |
| 31 Mar 2025 | Q1 | 100.0% | -391500.0% | -13.8% | -12.4% | 0.01 | 15.85 | -4.8 |
| 31 Dec 2024 | Q4 | 100.0% | -463600.0% | -18.8% | -16.6% | 0.01 | 13.11 | -5.5 |
| 30 Sept 2024 | Q3 | 100.0% | -456900.0% | -17.1% | -15.5% | 0.01 | 16.87 | -4.8 |
| 30 Jun 2024 | Q2 | 100.0% | -492800.0% | -16.2% | -14.2% | 0.01 | 11.30 | -5.2 |
| 31 Mar 2024 | Q1 | -2040.0% | -487880.0% | -14.1% | -13.0% | 0.00 | 16.55 | -7.4 |
| 31 Dec 2023 | Q4 | 100.0% | -85516.2% | -16.3% | -15.0% | 0.00 | 17.26 | -5.2 |